6.97
+0.37
+(5.61%)
At close: January 10 at 4:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | -- | 2 | 2 |
| Avg. Estimate | 15.58M | -- | 58.13M | 136.43M |
| Low Estimate | 14.3M | -- | 56.85M | 92.33M |
| High Estimate | 16.85M | -- | 59.41M | 180.53M |
| Year Ago Sales | 20.59M | -- | 84.51M | 58.13M |
| Sales Growth (year/est) | -24.35% | -- | -31.22% | 134.70% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| FBIOP | -- | -- | -- | -- |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Related Tickers
ATXI Avenue Therapeutics, Inc.
1.8114
-4.16%
CDIOW Cardio Diagnostics Holdings, Inc.
0.0780
-2.26%
CKPT Checkpoint Therapeutics, Inc.
3.1600
-1.56%
VALN Valneva SE
4.5400
-2.37%
E4NA.F Arovella Therapeutics Limited
0.1000
+5.82%
DRMAW Dermata Therapeutics, Inc.
0.0149
+34.23%
COEPW Coeptis Therapeutics Holdings, Inc.
0.0287
+32.87%
TYP.AX TRYPTAMINE FPO [TYP]
0.0370
-5.13%
DYAI Dyadic International, Inc.
1.6500
-4.35%
ATNFW 180 Life Sciences Corp.
0.0100
-4.76%